Skip to main content

Table 1 Characteristics of the 97 postmenopausal patients with estrogen receptor alpha-positive breast tumors and relation to relapse-free survival

From: Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma

   Relapse-free survival
  Number of patients Relapses (%) P a
Age    
   ≤ 70 years 47 18 (40.0) NS (0.89)
   > 70 years 50 14 (26.5)  
Histological gradeb,c    
   I + II 77 20 (26.0) 0.0057
   III 19 11 (57.9)  
Lymph node status    
   0 16 1 (6.2) 0.0018
   1–3 52 15 (28.8)  
   > 3 29 16 (55.2)  
Macroscopic tumor sizec    
   ≤ 30 mm 66 18 (27.3) 0.028
   > 30 mm 30 14 (46.7)  
Estrogen receptor alpha RNA status   
   Low 33 16 (48.5) NS (0.078)
   Intermediate 32 6 (18.8)  
   High 32 10 (31.2)  
Estrogen receptor beta RNA status   
   Low 33 5 (15.1) NS (0.062)
   Intermediate 32 14 (43.8)  
   High 32 13 (40.6)  
  1. a P value, log-rank test. NS, not significant. b Scarff Bloom Richardson classification. c Information available for 96 patients.